NAV-2729 is a dual Arf1/Arf6 inhibitor and is more effective towards Arf1 than Arf6. Moreover, NAV-2729 is an inhibitor of human FATP2 with a Ki value of 17.18 μM for inhibition of C1-BODIPY-C12 uptake into Caco-2 cells.

KEYWORDS: NAV-2729 | Suppliers | Arf1/Arf6/FATP2 inhibitor | Grassofermata | NAV2729 | NAV 2729 | CB5 | CB 5 | CB-5 | CAS [419547-11-8] | [1219832-51-5] | GTP | Arf | Inhibitor | Enzymes | Fatty acid transport protein | Obesity | Type 2 diabetes | Coronary heart disease | SLC27A2 | Very long-chain acyl-CoA synthetase | VLACS | ADP-ribosylation factor 6